This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The analysis of the clinical study was based on 'intention to treat'. The primary health outcomes used in the analysis were histopathological findings for which stereotaxic core biopsy replaced a diagnostic surgical biopsy.
Effectiveness results
Pathologic findings at stereotaxis core biopsy were as follows: 106 cases (58%)-benign, 47 cases (26%)-malignant, 4 cases (2%)-unusual, 18 cases (10%) atypical and 7 cases (4%) inadequate. Use of stereotaxis core biopsy spared 140 (77%)of 182 patients a diagnostic surgical procedure. This included 102 of 110 patients for whom stereotaxis core biopsy revealed benign histologic findings without atypia and 38 (81%) of 47 patients for whom stereotaxis biopsy revealed malignant disease. The histopathologic findings for which stereotaxis core biopsy did not replace a diagnostic surgical procedure were: atypical hyperplasia (18 cases), inadequate specimen (7 cases), carcinoma (9 cases), benign histologic condition requiring further investigation (4 cases), other benign condition (4 cases), in total-42 cases.
Clinical conclusions
The use of stereotaxis core biopsy with a 14-gauge needle has shown promise as a sensitive and specific means for diagnosis of breast lesions.
Measure of benefits used in the economic analysis
Histopathologic findings for which stereotaxic core biopsy replaced a diagnostic surgical procedure.
Direct costs
Costs and quantities were not reported separately. Direct health service costs were considered for: needle core biopsy of the breast, stereotaxis localisation, pathologic analysis, surgery, anaesthesia, specimen radiography, personnel, facilities. Professional costs of stereotaxis core biopsy and surgical procedure were estimated from 1993 Medicare and Relative Value for Physicians (RVP) data. Ad hoc calculations were used to estimate hospital costs. Cost of Hospital stay from 1993 official statistical date.
Indirect Costs
Time lost from work was considered. Costs and quantities were reported separately. The number of workdays lost was guessed. Wage data were derived from 1992 governmental data.
Currency

US dollars ($)
Sensitivity analysis
No sensitivity analysis was carried out.
Estimated benefits used in the economic analysis
Use of stereotaxis core biopsy spared 140 (77%) of 182 patients a diagnostic surgical procedure. This included 102 of 110 patients for whom stereotaxis core biopsy revealed benign histologic findings without atypia and 38 (81%) of 47 patients for whom stereotaxis biopsy revealed malignant disease. The histopathologic findings for which stereotaxis core biopsy did not replace a diagnostic surgical procedure were: atypical hyperplasia (18 cases), inadequate specimen (7 cases), carcinoma (9 cases), benign histologic condition requiring further investigation (4 cases), other benign condition (4 cases), in total-42 cases.
